Hui Li

Dr. Hui Li is the President and CEO of Adcentrx Therapeutics with over 20 years of drug discovery and business development experience in the biotech and pharmaceutical industry. Prior to founding Adcentrx, he was the CEO of Levena Biopharma, a subsidiary of Sorrento Therapeutics, focusing on antibody-drug conjugate (ADC) development. He also served as SVP of Business Development and General Manager of China Operations at Sorrento Therapeutics. During his time at Levena, he was responsible for developing a portfolio of site-specific ADC products and establishing a GMP production site to support clinical development of both internal and external ADC programs. Before Levena, he served as Executive Director of Business Development at PPD and Head of Business Development at its pre-clinical division BioDuro. Prior to joining PPD, he spent 10 years at Pfizer Global Research & Development, where he led a number of programs in the areas of oncology, diabetes, antiviral, and ophthalmology, which successfully progressed into clinical development.

Dr. Hui Li received his B.S. in Chemistry from Peking University and his Ph.D. in Organic Chemistry from University of California, San Diego.